SecBot SecBot
8-K ·Filed Mar 30, 2026

BGMSP

Bio Green Med Solution, Inc.
MIXED
Impact 6/10
Horizonweeks Processed7mo ago SEC0001493152-26-013611
earnings-rerun-backfill
Actionable Insight ◆ Mixed

Monitor upcoming 10-K for details on the warrant exchange accounting and whether fire safety revenue growth is sustainable. The deemed dividend is non-cash but significantly dilutive to shareholders.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
BGMSP ▲ +217.02% at T+60d
NEUTRAL call +217.02% · α vs SPY +204.63% · entry $0.2497 → $0.7916
Entry = T+0 close
Mar 30, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.75%
$0.2497
settled 7mo ago
T+5d
+166.67%
call +166.67% · α +162.72%
$0.6658
settled 7mo ago
T+20d
+328.95%
call +328.95% · α +319.53%
$1.07
settled 6mo ago
T+60d
+217.02%
call +217.02% · α +204.63%
$0.7916
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Bio Green Med Solution reported full-year 2025 results reflecting its strategic shift from biopharma to fire safety, with $747K in new product revenue. However, net loss applicable to common shareholders ballooned to $14.1 million due to a $11 million deemed dividend from warrant exchanges. Cash reserves remain sufficient into Q3 2026.

Key Financial Metrics

EPS
−$6.45
Revenue
$747.0K
Rating
in line
Gross Margin
18.35%

Key Facts

  • Reported $747K in fire safety product revenue for 2025, up from $0 in 2024
  • Net loss applicable to common shareholders was $14.09 million in 2025 vs $11.21 million in 2024
  • Deemed dividend on warrant exchange totaled $11.03 million in 2025
  • Cash and cash equivalents were $3.5 million as of December 31, 2025
  • Company completed acquisition of Fitters Sdn. Bhd. on September 12, 2025

Financial Impact

$11.03 million deemed dividend from warrant exchanges increased net loss

net lossearnings per shareshareholder equity

Risk Factors

  • High dilution from warrant exchanges impacting shareholder value
  • Transition risk in shifting from biopharma to fire safety business
  • Limited revenue scale in new fire safety segment

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-013611
Document: form8-k.htm0001493152-26-013611
Document: 0001493152-26-013611-index-headers.html0001493152-26-013611
Document: 0001493152-26-013611-index.html0001493152-26-013611
Document: 0001493152-26-013611.txt0001493152-26-013611
8-K Data (Synthetic)0001493152-26-013611
6 reports for BGMSP
Performance horizon
25% Hit rate @ T+20 1 of 4 directional calls Went positive at some point 1 of 4 best @ T+20▲ +51.72%May 14, 2026
Filters
Rows
Reports for BGMSP — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
8-K
BEARISH ★ 5/10
$0.7000 $1.46▼ −108.57%▼ −104.68%$3.00 (−328.57%)
Jun 4, 2026
20w ago
425
BEARISH ★ 7/10
$0.6943 $1.40▼ −101.64%▼ −99.52%$3.00 (−332.09%)
Jun 4, 2026
20w ago
8-K
BEARISH ★ 7/10
$0.6943 $1.40▼ −101.64%▼ −99.52%$3.00 (−332.09%)
May 14, 2026
23w ago
8-K
BEARISH ★ 6/10
$1.45 $0.7000▲ +51.72%▲ +53.84%$3.00 (−106.90%)
Apr 13, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$0.9155 $0.8626▼ −5.78%▼ −13.53%$3.00 (+227.69%)
Mar 30, 2026
30w ago
8-K
MIXED ★ 6/10
$0.2497 $1.07▲ +328.95%▲ +319.53%$3.00 (+1101.44%)
Showing 6 of 6

US Market Status

Market Closed — Opens Wed (11h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026